English | 简体中文 | 繁體中文 | 한국어
 English Press Releases
 Medicine BioTech
EC Healthcare Signs Inaugural Dual-Tranche Sustainability-Linked Facility, The First-of-its-Kind in Hong Kong Healthcare Industry
Jun 21, 2022 12:48 HKT
Sirnaomics Announces Publication of STP705 Clinical Study Results for Treatment of isSCC in the Peer-Reviewed Journal of Drugs in Dermatology
Jun 16, 2022 11:42 HKT
SinoMab Dosed First Healthy Subject in Phase I Clinical Trial of SM17 in the U.S.
Jun 15, 2022 13:03 HKT
Breakthrough Cooperation of Legend Capital's Cross-border Portfolio Companies: Innovent and Etana Jointly Announce the Approval of Bevagen by the BPOM
Jun 15, 2022 12:08 HKT
SINGAPORE ANNUAL MEETING: DIA and CoRE Gathering Key Healthcare Experts in Neutral Forum to Discuss Regulatory News and Drug Development
Jun 15, 2022 08:30 HKT
Novotech's APAC and USA Leadership Teams at BIO 2022
Jun 14, 2022 22:00 HKT
Olympus to Use 100% Renewable Electricity at R&D and Manufacturing Sites in Japan
Jun 14, 2022 12:00 HKT
Malaysian Genomics Resource Centre Berhad Gets Affected Issuer Status Uplifted
Jun 13, 2022 12:00 HKT
SinoMab Announces IND Application for SN1011 Accepted by NMPA CDE
Jun 09, 2022 12:48 HKT
Hua Medicine Announces Dorzagliatin can Restore Glucose Sensitivity and Early Phase Insulin Secretion in T2DM and GCK-MODY Patients at ADA 2022
Jun 07, 2022 10:15 HKT
Novotech Sponsors Endpoints ASCO 2022 Expert Panel on Accelerating Oncology Clinical Trials in China
Jun 06, 2022 18:00 HKT
EC Healthcare Forms a Joint Venture with KaiLong and Asia Allied Infrastructure
Jun 06, 2022 10:35 HKT
CUHK Professor Elaine Chow Receives "2022 Women's Interprofessional Network of the American Diabetes Association Abstract Award" for Outstanding Research and Care in Diabetes
Jun 05, 2022 09:07 HKT
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies
Jun 02, 2022 21:00 HKT
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies
Jun 02, 2022 21:00 HKT
Novotech Sponsors Pre-ASCO China Summit Panels on Early Phase Oncology Trials, Regulatory Strategy for China and US
Jun 02, 2022 18:00 HKT
Connected Transactions Involving Subscription by Vivo Suzhou Fund and Centerlab for TOT BIOPHARM Shares
Jun 02, 2022 09:37 HKT
Connected Transactions Involving Subscription by Vivo Suzhou Fund and Centerlab for TOT BIOPHARM Shares
Jun 01, 2022 12:08 HKT
Sirnaomics Launches Phase I Clinical Trial of RNAi Therapeutic STP705 in Adults Undergoing Abdominoplasty for Medical Cosmetology Treatment
May 30, 2022 15:38 HKT
The APCO Bone Health QI Tool Kit - Putting a brake on fractures in the world's most populous & fastest ageing region
May 24, 2022 08:21 HKT
<< Previous  Next >>
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: